Eraddication of Helicobacter pylori for quadruple therapy with base of Clarithromycin compared with Levofloxaci
Phase 3
Recruiting
- Conditions
- Helicobacter pylori infection.Helicobacter pylorB96.81
- Registration Number
- IRCT20171223038001N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Aged 18 years and older
Patients with dyspepsia and upper digestive tract symptoms
Peptic Ulcers in Upper Gastrointestinal Endoscopy
Helicobacter pylori infection in rapid test of urease
The desire to participate in the study
Lack of severe illness
Not having a history of upper gastrointestinal surgery
Not taking antibiotics, PPIs and NSAIDs in the last three months
Not having eradication history of Helicobacter pylori
Absence of ContraIndications for the Consumption of quadruple therapy
Exclusion Criteria
Low drug intake (for any reason)
Incidence of severe drug complications during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of Helicobacter pylori infection. Timepoint: Stool antigen Helicobacter pylori test 4 weeks after discontinuation of treatment. Method of measurement: Stool antigen Helicobacter pylori test.
- Secondary Outcome Measures
Name Time Method Dyspepsia severity. Timepoint: Before treatment and 4 weeks after treatment. Method of measurement: questionnaire.